vs
Side-by-side financial comparison of NorthEast Community Bancorp, Inc. (NECB) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
NorthEast Community Bancorp, Inc. is the larger business by last-quarter revenue ($26.4M vs $18.3M, roughly 1.4× ROCKWELL MEDICAL, INC.). NorthEast Community Bancorp, Inc. runs the higher net margin — 40.9% vs -3.0%, a 43.9% gap on every dollar of revenue. On growth, NorthEast Community Bancorp, Inc. posted the faster year-over-year revenue change (3.9% vs -25.6%). NorthEast Community Bancorp, Inc. produced more free cash flow last quarter ($50.8M vs $2.2M). Over the past eight quarters, NorthEast Community Bancorp, Inc.'s revenue compounded faster (1.8% CAGR vs -10.1%).
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NECB vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.4M | $18.3M |
| Net Profit | $10.8M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 59.0% | -2.2% |
| Net Margin | 40.9% | -3.0% |
| Revenue YoY | 3.9% | -25.6% |
| Net Profit YoY | 5.8% | 26.7% |
| EPS (diluted) | $0.78 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.4M | $18.3M | ||
| Q3 25 | $27.0M | $15.9M | ||
| Q2 25 | $25.9M | $16.1M | ||
| Q1 25 | $25.5M | $18.9M | ||
| Q4 24 | $25.4M | $24.7M | ||
| Q3 24 | $27.6M | $28.3M | ||
| Q2 24 | $27.0M | $25.8M | ||
| Q1 24 | $25.5M | $22.7M |
| Q4 25 | $10.8M | $-554.0K | ||
| Q3 25 | $11.9M | $-1.8M | ||
| Q2 25 | $11.2M | $-1.5M | ||
| Q1 25 | $10.6M | $-1.5M | ||
| Q4 24 | $10.2M | $-756.0K | ||
| Q3 24 | $12.7M | $1.7M | ||
| Q2 24 | $12.8M | $343.0K | ||
| Q1 24 | $11.4M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 59.0% | -2.2% | ||
| Q3 25 | 61.6% | -9.9% | ||
| Q2 25 | 59.5% | -8.4% | ||
| Q1 25 | 57.4% | -7.2% | ||
| Q4 24 | 57.0% | -2.1% | ||
| Q3 24 | 63.6% | 6.8% | ||
| Q2 24 | 65.6% | 2.0% | ||
| Q1 24 | 62.7% | -5.8% |
| Q4 25 | 40.9% | -3.0% | ||
| Q3 25 | 44.0% | -11.0% | ||
| Q2 25 | 43.1% | -9.3% | ||
| Q1 25 | 41.4% | -8.0% | ||
| Q4 24 | 40.1% | -3.1% | ||
| Q3 24 | 45.9% | 5.9% | ||
| Q2 24 | 47.5% | 1.3% | ||
| Q1 24 | 44.5% | -7.6% |
| Q4 25 | $0.78 | $-0.01 | ||
| Q3 25 | $0.87 | $-0.05 | ||
| Q2 25 | $0.82 | $-0.05 | ||
| Q1 25 | $0.78 | $-0.04 | ||
| Q4 24 | $0.74 | $-0.02 | ||
| Q3 24 | $0.95 | $0.04 | ||
| Q2 24 | $0.97 | $0.01 | ||
| Q1 24 | $0.86 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $81.2M | $10.7M |
| Total DebtLower is stronger | $70.0M | — |
| Stockholders' EquityBook value | $351.7M | $37.0M |
| Total Assets | $2.1B | $57.1M |
| Debt / EquityLower = less leverage | 0.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.2M | $10.7M | ||
| Q3 25 | $64.3M | $13.6M | ||
| Q2 25 | $59.4M | $12.5M | ||
| Q1 25 | $89.5M | $11.4M | ||
| Q4 24 | $78.3M | $15.7M | ||
| Q3 24 | $97.8M | $12.3M | ||
| Q2 24 | $113.9M | $11.9M | ||
| Q1 24 | $107.4M | $6.6M |
| Q4 25 | $70.0M | — | ||
| Q3 25 | $170.0M | — | ||
| Q2 25 | $135.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $7.0M | — | ||
| Q2 24 | $47.0M | — | ||
| Q1 24 | $47.0M | — |
| Q4 25 | $351.7M | $37.0M | ||
| Q3 25 | $344.0M | $37.0M | ||
| Q2 25 | $336.7M | $30.4M | ||
| Q1 25 | $327.2M | $31.5M | ||
| Q4 24 | $318.3M | $32.6M | ||
| Q3 24 | $309.6M | $29.1M | ||
| Q2 24 | $300.0M | $23.5M | ||
| Q1 24 | $288.9M | $20.6M |
| Q4 25 | $2.1B | $57.1M | ||
| Q3 25 | $2.1B | $57.5M | ||
| Q2 25 | $2.0B | $52.6M | ||
| Q1 25 | $1.9B | $54.0M | ||
| Q4 24 | $2.0B | $59.2M | ||
| Q3 24 | $2.0B | $57.1M | ||
| Q2 24 | $1.9B | $53.0M | ||
| Q1 24 | $1.9B | $50.7M |
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.6M | $2.3M |
| Free Cash FlowOCF − Capex | $50.8M | $2.2M |
| FCF MarginFCF / Revenue | 192.3% | 12.0% |
| Capex IntensityCapex / Revenue | 6.6% | 0.5% |
| Cash ConversionOCF / Net Profit | 4.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | $89.9M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.6M | $2.3M | ||
| Q3 25 | $14.1M | $-1.3M | ||
| Q2 25 | $15.6M | $1.8M | ||
| Q1 25 | $10.9M | $-3.5M | ||
| Q4 24 | $48.7M | $865.0K | ||
| Q3 24 | $14.4M | $4.3M | ||
| Q2 24 | $11.1M | $1.4M | ||
| Q1 24 | $12.9M | $-2.4M |
| Q4 25 | $50.8M | $2.2M | ||
| Q3 25 | $13.6M | $-1.5M | ||
| Q2 25 | $14.9M | $1.7M | ||
| Q1 25 | $10.6M | $-3.5M | ||
| Q4 24 | $48.2M | $470.0K | ||
| Q3 24 | $14.2M | $4.1M | ||
| Q2 24 | $11.0M | $1.2M | ||
| Q1 24 | $12.8M | $-2.5M |
| Q4 25 | 192.3% | 12.0% | ||
| Q3 25 | 50.5% | -9.6% | ||
| Q2 25 | 57.3% | 10.5% | ||
| Q1 25 | 41.4% | -18.8% | ||
| Q4 24 | 189.3% | 1.9% | ||
| Q3 24 | 51.5% | 14.4% | ||
| Q2 24 | 40.8% | 4.5% | ||
| Q1 24 | 50.3% | -11.1% |
| Q4 25 | 6.6% | 0.5% | ||
| Q3 25 | 1.6% | 1.4% | ||
| Q2 25 | 2.9% | 1.0% | ||
| Q1 25 | 1.5% | 0.3% | ||
| Q4 24 | 2.0% | 1.6% | ||
| Q3 24 | 0.6% | 0.7% | ||
| Q2 24 | 0.5% | 1.1% | ||
| Q1 24 | 0.3% | 0.6% |
| Q4 25 | 4.86× | — | ||
| Q3 25 | 1.18× | — | ||
| Q2 25 | 1.40× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 4.77× | — | ||
| Q3 24 | 1.14× | 2.57× | ||
| Q2 24 | 0.87× | 4.20× | ||
| Q1 24 | 1.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NECB
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
